[Breast MR imaging: validated indications and unsolved problems].
The contribution of breast MR imaging for second intention after a complete assessment (mammography, ultra-sound, and possibly histological) of breast pathology is not any more to show. Its limits are due primarily to its great sensitivity responsible for false positive (20 to 40 %) and to the difficulty in carrying out biopsies under guidance IRM of the lesions not found in second intention by the mammography and ultrasound (50 to 75 %). Its use reasoned by respecting the indications recognized as useful and validated for the clinical plan is an imperative condition to avoid noxious assumptions of responsibility of the patients.
Taïeb
Sophie
S
Département d'imagerie, Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. s-taieb@o-lambret.fr
Ceugnart
Luc
L
D001940:Breast / Q000473:pathology*; D001941:Breast Diseases / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology*; D002114:Calcinosis / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000592:standards*; D012680:Sensitivity and Specificity